NSE: BIOCON | BSE: 532523

Slowing Down Stock

Download real time

331.30 2.15 (0.65%)

27.50% Gain from 52W Low

997.4K NSE+BSE Volume

NSE 17 Apr, 2025 3:31 PM (IST)

39,775.9

Market Cap

Market Leader

1.2

Beta 1Year

Very High Volatility

Signs Agreement

Biocon's arm enters a settlement and license agreement with Regeneron to market Yesafili in the US See details

Biocon Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Biocon Ltd. on BSE

Load latest

Is Biocon Ltd. worth buying?

714 Votes:

Buy 75.07%

Sell 16.39%

Hold 8.54%

RESEARCH REPORTS

Buy SEE REPORTS >

Buy SEE REPORTS >